Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EBIT: 2015-2025

Historic EBIT for Wave Life Sciences (WVE) over the last 11 years, with Sep 2025 value amounting to -$56.4 million.

  • Wave Life Sciences' EBIT rose 11.83% to -$56.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$135.9 million, marking a year-over-year increase of 10.59%. This contributed to the annual value of -$110.4 million for FY2024, which is 62.37% down from last year.
  • Latest data reveals that Wave Life Sciences reported EBIT of -$56.4 million as of Q3 2025, which was down 6.81% from -$52.8 million recorded in Q2 2025.
  • Over the past 5 years, Wave Life Sciences' EBIT peaked at $23.0 million during Q4 2024, and registered a low of -$63.9 million during Q3 2024.
  • For the 3-year period, Wave Life Sciences' EBIT averaged around -$30.7 million, with its median value being -$34.5 million (2024).
  • The largest annual percentage gain for Wave Life Sciences' EBIT in the last 5 years was 222.94% (2024), contrasted with its biggest fall of 1,538.23% (2024).
  • Wave Life Sciences' EBIT (Quarterly) stood at -$36.1 million in 2021, then dropped by 20.64% to -$43.6 million in 2022, then skyrocketed by 57.11% to -$18.7 million in 2023, then soared by 222.94% to $23.0 million in 2024, then rose by 11.83% to -$56.4 million in 2025.
  • Its EBIT was -$56.4 million in Q3 2025, compared to -$52.8 million in Q2 2025 and -$49.8 million in Q1 2025.